137 related articles for article (PubMed ID: 11680569)
1. Total and active thymoglobulin levels: effects of dose and sensitization on serum concentrations.
Regan JF; Lyonnais C; Campbell K; Smith LV; Buelow R;
Transpl Immunol; 2001 Oct; 9(1):29-36. PubMed ID: 11680569
[TBL] [Abstract][Full Text] [Related]
2. Sensitization following Thymoglobulin and Atgam rejection therapy as determined with a rapid enzyme-linked immunosorbent assay. US Thymoglobulin Multi-Center Study Group.
Regan JF; Campbell K; Van Smith L; Schroeder TJ; Womble D; Kano J; Buelow R
Transpl Immunol; 1999 Jun; 7(2):115-21. PubMed ID: 10544442
[TBL] [Abstract][Full Text] [Related]
3. Results of the double-blind, randomized, multicenter, phase III clinical trial of Thymoglobulin versus Atgam in the treatment of acute graft rejection episodes after renal transplantation.
Gaber AO; First MR; Tesi RJ; Gaston RS; Mendez R; Mulloy LL; Light JA; Gaber LW; Squiers E; Taylor RJ; Neylan JF; Steiner RW; Knechtle S; Norman DJ; Shihab F; Basadonna G; Brennan DC; Hodge EE; Kahan BD; Kahan L; Steinberg S; Woodle ES; Chan L; Ham JM; Schroeder TJ
Transplantation; 1998 Jul; 66(1):29-37. PubMed ID: 9679818
[TBL] [Abstract][Full Text] [Related]
4. Characterization of anti-thymoglobulin, anti-Atgam and anti-OKT3 IgG antibodies in human serum with an 11-min ELISA.
Regan J; Campbell K; van Smith L; Pouletty P; Schroeder TJ; Guttmann RD; Buelow R
Transpl Immunol; 1997 Mar; 5(1):49-56. PubMed ID: 9106335
[TBL] [Abstract][Full Text] [Related]
5. A randomized, double-blinded comparison of Thymoglobulin versus Atgam for induction immunosuppressive therapy in adult renal transplant recipients.
Brennan DC; Flavin K; Lowell JA; Howard TK; Shenoy S; Burgess S; Dolan S; Kano JM; Mahon M; Schnitzler MA; Woodward R; Irish W; Singer GG
Transplantation; 1999 Apr; 67(7):1011-8. PubMed ID: 10221486
[TBL] [Abstract][Full Text] [Related]
6. Comparison of efficacy and safety between rabbit anti-thymocyte globulin and anti-T lymphocyte globulin in kidney transplantation from donation after cardiac death: a retrospective cohort study.
Chen GD; Lai XQ; Ko DS; Qiu J; Wang CX; Han M; Li J; Huang G; He XS; Chen LZ
Nephrology (Carlton); 2015 Aug; 20(8):539-43. PubMed ID: 25808082
[TBL] [Abstract][Full Text] [Related]
7. Thymoglobulin reverses acute renal allograft rejection better than ATGAM--a double-blinded randomized clinical trial.
Tesi RJ; Kano JM; Horn HR; Schroeder T
Transplant Proc; 1997 Nov; 29(7A):21S-23S. PubMed ID: 9366922
[No Abstract] [Full Text] [Related]
8. Economics of the antithymocyte globulins Thymoglobulin and Atgam in the treatment of acute renal transplant rejection.
Schnitzler MA; Woodward RS; Lowell JA; Amir L; Schroeder TJ; Singer GG; Brennan DC
Pharmacoeconomics; 2000 Mar; 17(3):287-93. PubMed ID: 10947303
[TBL] [Abstract][Full Text] [Related]
9. Use of rabbit antithymocyte globulin in cardiac transplantation. Relationship of serum clearance rates to clinical outcome.
Bieber CP; Griepp RB; Oyer PE; Wong J; Stinson EB
Transplantation; 1976 Nov; 22(5):478-88. PubMed ID: 793103
[TBL] [Abstract][Full Text] [Related]
10. Five-year follow up of thymoglobulin versus ATGAM induction in adult renal transplantation.
Hardinger KL; Schnitzler MA; Miller B; Lowell JA; Shenoy S; Koch MJ; Enkvetchakul D; Ceriotti C; Brennan DC
Transplantation; 2004 Jul; 78(1):136-41. PubMed ID: 15257052
[TBL] [Abstract][Full Text] [Related]
11. A prospective, randomized, double-blinded comparison of thymoglobulin versus Atgam for induction immunosuppressive therapy: 10-year results.
Hardinger KL; Rhee S; Buchanan P; Koch M; Miller B; Enkvetchakul D; Schuessler R; Schnitzler MA; Brennan DC
Transplantation; 2008 Oct; 86(7):947-52. PubMed ID: 18852661
[TBL] [Abstract][Full Text] [Related]
12. In Vitro Effects of Thymoglobulin in Human Embryonic Kidney Cell Line (HEK293) in Culture.
Jurenec F; Mihovilović K; Špiranec K; Sinđić A; Knotek M
Transplant Proc; 2016 Oct; 48(8):2840-2844. PubMed ID: 27788827
[TBL] [Abstract][Full Text] [Related]
13. Induction antibody therapy in renal transplantation using early steroid withdrawal: long-term results comparing anti-IL2 receptor and anti-thymocyte globulin.
Libório AB; Mendoza TR; Esmeraldo RM; Oliveira ML; Paes FJ; Silva Junior GB; Daher EF
Int Immunopharmacol; 2011 Nov; 11(11):1832-6. PubMed ID: 21835269
[TBL] [Abstract][Full Text] [Related]
14. Treatment of Biopsy-Proven Acute Antibody-Mediated Rejection Using Thymoglobulin (ATG) Monotherapy and a Combination of Rituximab, Intravenous Immunoglobulin, and Plasmapheresis: Lesson Learned from Primary Experience.
Zheng J; Xue W; Qing X; Jing X; Hou J; Tian X; Guo Q; He X; Cai J
Clin Transpl; 2014; ():223-30. PubMed ID: 26281149
[TBL] [Abstract][Full Text] [Related]
15. Comparison of polyclonal induction agents in pediatric renal transplantation.
Brophy PD; Thomas SE; McBryde KD; Bunchman TE
Pediatr Transplant; 2001 Jun; 5(3):174-8. PubMed ID: 11422819
[TBL] [Abstract][Full Text] [Related]
16. Safety, efficacy, and cost analysis of thymoglobulin induction therapy with intermittent dosing based on CD3+ lymphocyte counts in kidney and kidney-pancreas transplant recipients.
Peddi VR; Bryant M; Roy-Chaudhury P; Woodle ES; First MR
Transplantation; 2002 May; 73(9):1514-8. PubMed ID: 12023634
[TBL] [Abstract][Full Text] [Related]
17. New trends in transplantation: the use of Thymoglobulin.
Ballen K
Expert Opin Drug Metab Toxicol; 2009 Mar; 5(3):351-5. PubMed ID: 19292599
[TBL] [Abstract][Full Text] [Related]
18. Immune reconstitution with two different rabbit polyclonal anti-thymocytes globulins.
Bamoulid J; Crepin T; Gaiffe E; Laheurte C; Moulin B; Frimat L; Rieu P; Mousson C; Durrbach A; Heng AE; Rebibou JM; Saas P; Courivaud C; Ducloux D
Transpl Immunol; 2017 Dec; 45():48-52. PubMed ID: 28941751
[TBL] [Abstract][Full Text] [Related]
19. In vivo characterization of rabbit anti-mouse thymocyte globulin: a surrogate for rabbit anti-human thymocyte globulin.
Ruzek MC; Neff KS; Luong M; Smith KA; Culm-Merdek K; Richards SM; Williams JM; Perricone M; Garman RD
Transplantation; 2009 Jul; 88(2):170-9. PubMed ID: 19623011
[TBL] [Abstract][Full Text] [Related]
20. The effect of low and ultra-low dosages Thymoglobulin on peripheral T, B and NK cells in kidney transplant recipients.
Kho MM; Bouvy AP; Cadogan M; Kraaijeveld R; Baan CC; Weimar W
Transpl Immunol; 2012 Jun; 26(4):186-90. PubMed ID: 22410573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
